Morphine withdrawal is modified in pituitary adenylate cyclase-activating polypeptide type I-receptor-deficient mice

Molecular Brain Research

Volumn 110, Issue 1, 2003, Pages 109-118

  Martin, Miquel ^a   Otto, Christiane ^b   Santamarta, Maria Teresa ^c   Torrecilla, Maria ^c   Pineda, Joseba ^c   Schütz, Günther ^b   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Knockout mice; Locus coeruleus; Morphine withdrawal; Nociception; Pituitary adenylate cyclase activating polypeptide type I receptor; Writhing test

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MORPHINE; NALOXONE; RECEPTOR SUBUNIT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN STEM; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; LOCOMOTION; LOCUS CERULEUS; MORPHINE ADDICTION; MOUSE; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; TASK PERFORMANCE; VISCERAL PAIN; WILD TYPE; WITHDRAWAL SYNDROME; WRITHING TEST;

ANALGESICS, OPIOID; ANIMALS; ELECTROPHYSIOLOGY; LOCUS COERULEUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MOTOR ACTIVITY; NEUROPEPTIDES; NOCICEPTORS; PAIN MEASUREMENT; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037474102     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00646-0     Document Type: Article

References (47)

1. Anderson S.T., Curlewis J.D. PACAP stimulates dopamine neuronal activity in the medial basal hypothalamus and inhibits prolactin. Brain Res. 790:1998;343-346.
2. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol. 48:1998;303-331.
3. Bals-Kubik R., Ableitner A., Herz A., Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495.
4. Christophe J. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta. 1154:1993;183-199.
5. De Vries T.J., Shoffelmeer A.N.M., Binnekade R., Mulder A.H., Vanderschuren L.J.M.J. Drug-induced reinstatement of heroin and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur. J. Neurosci. 10:1998;3565-3571.
6. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
7. Dickinson T., Fleetwood-Walker S., Mitchell R., Lutz E.M. Evidence for roles of vasoactive polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs. Neuropeptides. 31:1997;175-185.
8. Dickinson T., Mitchell R., Robberecht P., Fleetwood-Walker S.M. The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy. Neuropharmacology. 38:1999;167-180.
9. Dun N.J., Miyazaki T., Tang H., Dun E.C. Pituitary adenylate cyclase activating polypeptide immunoreactivity in the rat spinal cord and medulla: implication of sensory and autonomic functions. Neuroscience. 73:1996;677-686.
10. Eddy N.B., Leimbach D. Synthetic analgesic (II): dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-396.
11. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58:1992;1168-1171.
12. Guyenet P.G., Young B.S. Projections of nucleus paragigantocellularis lateralis to locus coeruleus and other structures in rat. Brain Res. 406:1987;171-184.
13. Hahm S.H., Hsu C.M., Eiden L.E. PACAP activates calcium influx-dependent and -independent pathways to couple met-enkephalin secretion and biosynthesis in chromaffin cells. J. Mol. Neurosci. 11:1998;43-56.
14. Hao S., Takahata O., Iwasaki H. Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha2-adrenoreceptors in the rat tail-flick, tail pressure and formalin tests. Life Sci. 66:2000;195-204.
15. Hashimoto H., Nogi H., Mori K., Ohishi H., Shigemoto R., Yamamoto K., Matsuda T., Mizuno N., Nagata S., Baba A. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J. Comp. Neurol. 371:1996;567-577.
16. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
17. Jamen F., Persson K., Bertrand G., Rodriguez-Henche N., Puech R., Bockaert J., Ahren B., Brabet P. PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J. Clin. Invest. 105:2000;1307-1315.
18. Jongsma H., Pettersson L.M., Zhang Y.Z., Reimer M.K., Kanje M., Waldenstrom A., Sundler F., Danielsen N. Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor. Neuroreport. 12:2001;2215-2219.
19. Just L., Morl F., Barmann C., Olenik C., Meyer D.K. Evidence for cell specific regulation by PACAP38 of the proenkephalin gene expression in neocortical cells. Glia. 30:2000;242-252.
20. Kogan J.H., Nestler E.J., Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
21. Koob G.F. Neural mechanisms of drug reinforcement. Ann. NY Acad. Sci. 654:1992;171-191.
22. Koob G.F., LeMoal M. Drug abuse: hedonic homeostatic dysregulation. Science. 278:1997;52-58.
23. Koob G.F., Maldonado R., Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci. 15:1992;186-191.
24. Lane-Ladd S.B., Pineda J., Boundy V.A., Pfeuffer T., Krupinski J., Ahjajanian G.K., Nestler E.J. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological and behavioral evidence for a role in opiate dependence. J. Neurosci. 17:1997;7890-7901.
25. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:1993;3-8.
26. Macsai M., Szabo G., Telegdy G. Vasoactive intestinal polypeptide induces analgesia and impairs the antinociceptive effect of morphine in mice. Neuropeptides. 32:1998;557-562.
27. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21:1997;91-104.
28. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
29. Maldonado R., Blendy J.A., Tzavara E., Gass P., Roques B.P., Hanoune J., Schütz G. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science. 273:1996;657-659.
30. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 388:1997;586-589.
31. Moller K., Zhang Y.Z., Hakanson R., Luts A., Sjolund B., Uddmann R., Sundler F. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience. 57:1993;725-732.
32. Moser A., Scholz J., Gansle A. Pituitary adenylate cyclase-activating polypeptide (PACAP-27) enhances tyrosine hydroxylase activity in the nucleus accumbens of the rat. Neuropeptides. 33:1999;492-497.
33. Narita M., Dun S.L., Dun N.J., Tseng L.F. Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord. Eur. J. Pharmacol. 311:1996;121-126.
34. Noble F., Smadja C., Valverde O., Maldonado R., Coric P., Turcaud S., Fournie-Zaluski M.C., Roques B.P. Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) on the first orally active enkephalin-metabolizing enzyme inhibitor RB120. Pain. 73:1997;383-391.
35. Otto C., Zuschratter W., Gass P., Schütz G. Presynaptic localization of the PACAP-type-I-receptor in hippocampal and cerebellar mossy fibers. Mol. Brain Res. 66:1999;163-174.
36. Otto C., Kovalchuk Y., Wolfer D.P., Gass P., Martin M., Zuschratter W., Gröne H.J., Kellendonk C., Tronche F., Maldonado R., Lipp H.P., Konnerth A., Schütz G. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase-activating polypeptide-type-I-receptor-deficient mice. J. Neurosci. 21:2001;5520-5527.
37. Otto C., Martin M., Wolfer D.P., Lipp H.P., Maldonado R., Schütz G. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res. Mol. Brain Res. 92:2001;78-84.
38. Pineda J., Kogan J.H., Aghajanian G.K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16:1996;1389-1399.
39. Shioda S., Shuto Y., Somogyvari-Vigh A., Legradi G., Onda H., Coy D.H., Nakajo S., Arimura A. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci. Res. 28:1997;345-354.
40. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1995;808-815.
41. Shippenberg T.S., Heidbreder C., Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur. J. Pharmacol. 299:1996;33-39.
42. Valverde O., Ledent C., Beslot F., Parmentier M., Roques B.P. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Eur. J. Neurosci. 12:2000;533-539.
43. Vanderschuren L.J.M.J., Schmidt E.D., De Vries T.J., Van Moorsel C.A.P., Tilders F.J.H., Schoffelmeer A.N.M. A single exposure to amphetamine is sufficient to induce long-term behavioural, neuroendocrine and neurochemical sensitization in rats. J. Neurosci. 19:1999;9579-9586.
44. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions. Pharmacol. Rev. 52:2000;269-324.
45. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
46. Yamamoto T., Tatsuno I. Antinociceptive effect of intrathecally administered pituitary adenylate cyclase activating polypeptide (PACAP) on the rat formalin test. Neurosci. Lett. 184:1995;32-35.
47. Zhang Y., Malmberg A.B., Sjölund B., Yaksh T.L. The effect of pituitary adenylate cyclase activating peptide (PACAP) on the nociceptive formalin test. Neurosci. Lett. 207:1996;187-190.